Investing IdeasBrowse All StocksMarkets

Have your own idea? Try our Stock Screener

Header cover image

Danish (OMX) Pharma Industry Analysis

UpdatedDec 26, 2024
DataAggregated Company Financials
Companies4
  • 7D-15.8%
  • 3M-21.5%
  • 1Y-10.0%
  • YTD-9.9%

Over the last 7 days, the Pharma industry has dropped 16%, driven by Novo Nordisk declining 16%. Overall the industry is down 10.0% in 12 months. Looking forward, earnings are forecast to grow by 14% annually.

Industry Valuation and Performance

Has the Danish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Thu, 26 Dec 2024DKK 2.8tDKK 297.4bDKK 98.2b29.1x28.8x9.5x
Sat, 23 Nov 2024DKK 3.4tDKK 297.4bDKK 98.2b35.2x34.8x11.5x
Mon, 21 Oct 2024DKK 3.7tDKK 283.9bDKK 93.2b39.8x39.3x12.9x
Wed, 18 Sep 2024DKK 4.1tDKK 283.9bDKK 93.2b44.5x43.9x14.4x
Fri, 16 Aug 2024DKK 4.2tDKK 283.1bDKK 92.9b45.8x45.2x14.8x
Sun, 14 Jul 2024DKK 4.4tDKK 269.3bDKK 92.2b48.7x47.9x16.4x
Tue, 11 Jun 2024DKK 4.4tDKK 269.3bDKK 92.2b49.1x48.1x16.5x
Thu, 09 May 2024DKK 4.0tDKK 269.1bDKK 92.1b44.1x43.5x14.9x
Sat, 06 Apr 2024DKK 3.9tDKK 257.0bDKK 86.4b46.3x45.5x15.3x
Mon, 04 Mar 2024DKK 3.9tDKK 257.0bDKK 86.4b45.4x44.6x15x
Wed, 31 Jan 2024DKK 3.4tDKK 238.8bDKK 78.2b44.3x43.4x14.2x
Fri, 29 Dec 2023DKK 3.2tDKK 238.8bDKK 78.2b41.3x40.5x13.3x
Sun, 26 Nov 2023DKK 3.3tDKK 238.8bDKK 78.2b42.5x41.6x13.6x
Tue, 24 Oct 2023DKK 3.1tDKK 225.4bDKK 70.1b45.4x44.3x13.8x
Thu, 21 Sep 2023DKK 3.0tDKK 225.4bDKK 70.1b44.1x43.1x13.4x
Sat, 19 Aug 2023DKK 2.9tDKK 224.8bDKK 69.9b41.7x40.8x12.7x
Mon, 17 Jul 2023DKK 2.4tDKK 211.8bDKK 63.8b39x38.1x11.5x
Wed, 14 Jun 2023DKK 2.5tDKK 211.8bDKK 63.8b40x39.2x11.8x
Fri, 12 May 2023DKK 2.6tDKK 211.8bDKK 63.8b42.4x41.5x12.5x
Sun, 09 Apr 2023DKK 2.5tDKK 199.7bDKK 57.8b43.6x42.9x12.4x
Tue, 07 Mar 2023DKK 2.3tDKK 199.7bDKK 57.8b40.9x40.3x11.6x
Thu, 02 Feb 2023DKK 2.2tDKK 189.2bDKK 54.7b40.3x39.7x11.5x
Sat, 31 Dec 2022DKK 2.2tDKK 189.2bDKK 54.7b40.1x39.7x11.5x
Mon, 28 Nov 2022DKK 2.0tDKK 189.2bDKK 54.7b36.3x35.9x10.4x
Wed, 26 Oct 2022DKK 1.9tDKK 178.4bDKK 52.1b36.1x36.1x10.5x
Fri, 23 Sep 2022DKK 1.7tDKK 178.4bDKK 52.1b33.3x33.3x9.7x
Sun, 21 Aug 2022DKK 1.8tDKK 178.4bDKK 52.1b34.6x34.7x10.1x
Tue, 19 Jul 2022DKK 2.0tDKK 169.5bDKK 50.7b38.5x38.8x11.6x
Thu, 16 Jun 2022DKK 1.8tDKK 169.5bDKK 50.7b34.9x35.1x10.5x
Sat, 14 May 2022DKK 1.7tDKK 169.5bDKK 50.7b34x34.3x10.3x
Mon, 11 Apr 2022DKK 1.9tDKK 161.0bDKK 49.3b39.3x39.4x12.1x
Wed, 09 Mar 2022DKK 1.6tDKK 161.0bDKK 49.3b32.9x33.1x10.1x
Fri, 04 Feb 2022DKK 1.6tDKK 161.1bDKK 49.7b32.5x32.4x10x
Sun, 02 Jan 2022DKK 1.7tDKK 154.9bDKK 48.2b36.3x36.3x11.3x
Price to Earnings Ratio

36.3x


Total Market Cap: DKK 1.7tTotal Earnings: DKK 48.2bTotal Revenue: DKK 154.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Pharma Industry Price to Earnings3Y Average 39.7x20232024
Current Industry PE
  • Investors are pessimistic on the Danish Pharmaceuticals industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The industry is trading at a PE ratio of 28.8x which is lower than its 3-year average PE of 39.7x.
  • The 3-year average PS ratio of 12.4x is higher than the industry's current PS ratio of 9.5x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 27% per year over the last three years.
  • Revenues for these companies have grown 24% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Trends

Which industries have driven the changes within the Danish Healthcare industry?

DK Market-8.96%
Healthcare-13.95%
Pharma-15.83%
Pharma-15.83%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
HLUN B H. LundbeckDKK 41.642.3%
+DKK 932.5m		27.4%PE15.4x
ALK B ALK-AbellóDKK 157.101.5%
+DKK 508.7m		57.1%PE44.3x
Simply Wall St™
Simply Wall Street Pty Ltd
Level 7, 320 Pitt Street, Sydney
Download on the App StoreGet it on Google Play
Popular Markets
USAUUKINCAZA
About UsCareersPlans & PricingLogin
Help CenterLatest CoveragePodcastsAffiliate ProgramBusiness & EnterpriseWhat's New
Financial Services GuideTerms and ConditionsPrivacy Policy
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

ALK B

DKK 157.10

ALK-Abelló

7D

1.5%

1Y

57.1%

NOVO B

DKK 622.60

Novo Nordisk

7D

-16.2%

1Y

-10.8%

Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

Dec 23
Is Novo Nordisk (CPH:NOVO B) Using Too Much Debt?

STENO

DKK 1.32

Stenocare

7D

-5.7%

1Y

-50.0%

HLUN B

DKK 41.64

H. Lundbeck

7D

2.3%

1Y

27.4%